Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EMvision Medical Devices Ltd. ( (AU:EMV) ) just unveiled an announcement.
EMvision Medical Devices has notified the ASX that 2,550,000 listed options (EMVAP), which were exercisable at $2.25 and due to expire on 31 December 2025, have lapsed without being exercised or converted, effective 31 December 2025. The expiry of these options reduces the company’s pool of potential future share issuances from this class of securities, slightly simplifying its capital structure and removing a source of possible dilution for existing shareholders.
The most recent analyst rating on (AU:EMV) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMvision Medical Devices Ltd is an ASX-listed medical technology company (code: EMV) focused on developing and commercialising medical devices, operating within the healthcare and medical devices industry.
Average Trading Volume: 56,805
Technical Sentiment Signal: Sell
Current Market Cap: A$165.4M
Find detailed analytics on EMV stock on TipRanks’ Stock Analysis page.